dr. kris on adjuvant systemic therapy in nsclc
Published 5 years ago • 129 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
3:06
adjuvant versus neoadjuvant therapy in nsclc
-
1:40
dr. kris on predicting benefit with osimertinib in egfr nsclc
-
0:59
dr. weksler on neoadjuvant and adjuvant therapy in nsclc
-
1:22
dr. kris on combination chemotherapy approaches in nsclc
-
1:17
dr. kris on personalizing therapy in lung cancer
-
1:28
dr. kris on the future of immunotherapy and targeted therapy in lung cancer
-
1:48
dr. mark kris on immunotherapy and frontline options for patients with nsclc
-
10:20
role of adjuvant osimertinib in early stage nsclc
-
1:17
dr. kris on the challenges of treating lung cancer
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
1:21
dr. kris on the fda approval of dacomitinib in egfr nsclc
-
1:14
dr. kris discusses role of antiangiogenesis in lung cancer
-
2:20
dr. kris on the relay trial in egfr nsclc
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
0:32
dr. hak choy on radiation and immunotherapy in combination in lung cancer
-
20:16
adjuvant therapy in nsclc: is there any hope beyond chemotherapy?
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning
-
4:49
in early-stage nsclc, give nivolumab before or after surgery?